However, as the BAD peptide was much less efficient than the BIM peptide, it suggested that CLL cells may depend on additional BCL-2 family proteins for survival in scenarios, such as an alteration in tissue microenvironment (Vogler et al, 2009a). The gene discussed is BCL2; the disease is B-cell chronic lymphocytic leukemia.